Targeting leucine-rich repeat serine/threonine-protein kinase 2 sensitizes pancreatic ductal adenocarcinoma to anti-PD-L1 immunotherapy

Kang Sun(Zhejiang University), Xueli Bai(First Affiliated Hospital Zhejiang University)
Molecular Therapy
July 27, 2023
10.1016/j.ymthe.2023.07.021
Cited by 12

Related Papers

Integrated multiomic analysis reveals comprehensive tumour heterogeneity and novel immunophenotypic classification in hepatocellular carcinomas
|Gut|2019|335
Induced phase separation of mutant NF2 imprisons the cGAS-STING machinery to abrogate antitumor immunity
|Molecular Cell|2021|128
Targeting ubiquitin-specific protease 8 sensitizes anti-programmed death-ligand 1 immunotherapy of pancreatic cancer
|Cell Death and Differentiation|2022|82
Innate immune sensing of lysosomal dysfunction drives multiple lysosomal storage disorders
|Nature Cell Biology|2024|76
Tumour cell-derived debris and IgG synergistically promote metastasis of pancreatic cancer by inducing inflammation via tumour-associated macrophages
|British Journal of Cancer|2019|61